Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). M1 Kliniken AG's share price for the quarter that ended in Jun. 2023 was €7.98. M1 Kliniken AG's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 18.3 Mil. Therefore, M1 Kliniken AG's market cap for the quarter that ended in Jun. 2023 was €146.2 Mil.
M1 Kliniken AG's quarterly market cap
increased
from Jun. 2022 (€100.3 Mil) to Dec. 2022 (€165.9 Mil) but then
declined
from Dec. 2022 (€165.9 Mil) to Jun. 2023 (€146.2 Mil).
M1 Kliniken AG's annual market cap
declined
from Dec. 2020 (€171.7 Mil) to Dec. 2021 (€139.3 Mil) but then
increased
from Dec. 2021 (€139.3 Mil) to Dec. 2022 (€165.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. M1 Kliniken AG's Enterprise Value for Today is €257.1 Mil.
M1 Kliniken AG Market Cap Historical Data
The historical data trend for M1 Kliniken AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of M1 Kliniken AG's Market Cap
For the Medical Care Facilities subindustry, M1 Kliniken AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's Market Cap distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's Market Cap falls into.
M1 Kliniken AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
M1 Kliniken AG's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (XTER:M12) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
M1 Kliniken AG Market Cap Related Terms
Thank you for viewing the detailed overview of M1 Kliniken AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:M12 has been successfully added to your 